On the morning of December 28, the unveiling ceremony of the "Anhui Provicial Engineering Laboratory of Peptide Drugs" was held at the University of Science and Technology of China.
The "Anhui Provicial Engineering Laboratory of Peptide Drugs" was established based on the joint application of the University of Science and Technology of China (USTC) and Hefei KS-V Peptide Biological Technology Co., Ltd.
Anhui Provicial Engineering Laboratory of Peptide Drugs aims at the wave of innovative drugs development, focuses on major chronic diseases such as autoimmune diseases, diabetes, pain and depression, and carries out the development of key technologies for the research and development of innovative peptide drugs, and the R&D of innovative peptide drugs with independent intellectual property rights to accelerate scientific research, achieve the transition to industrialization, promote the rapid development of the innovative peptide drug market.